Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses
Avtorji:ID Laurie, Steven (Avtor)
ID Steyaert, Wouter (Avtor)
ID De Boer, Elke (Avtor)
ID Polavarapu, Kiran (Avtor)
ID Schuermans, Nika (Avtor)
ID Sommer, Anna K. (Avtor)
ID Demidov, German (Avtor)
ID Maver, Aleš (Avtor)
ID Peterlin, Borut (Avtor), et al.
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (10,60 MB)
MD5: C738E209A6CB2FCFF76842279B769329
 
URL URL - Izvorni URL, za dostop obiščite https://www.nature.com/articles/s41591-024-03420-w
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKC LJ - Univerzitetni klinični center Ljubljana
Povzetek:Genetic diagnosis of rare diseases requires accurate identification and interpretation of genomic variants. Clinical and molecular scientists from 37 expert centers across Europe created the Solve-Rare Diseases Consortium (Solve-RD) resource, encompassing clinical, pedigree and genomic rare-disease data (94.5% exomes, 5.5% genomes), and performed systematic reanalysis for 6,447 individuals (3,592 male, 2,855 female) with previously undiagnosed rare diseases from 6,004 families. We established a collaborative, two-level expert review infrastructure that allowed a genetic diagnosis in 506 (8.4%) families. Of 552 disease-causing variants identified, 464 (84.1%) were single-nucleotide variants or short insertions/deletions. These variants were either located in recently published novel disease genes (n = 67), recently reclassified in ClinVar (n = 187) or reclassified by consensus expert decision within Solve-RD (n = 210). Bespoke bioinformatics analyses identified the remaining 15.9% of causative variants (n = 88). Ad hoc expert review, parallel to the systematic reanalysis, diagnosed 249 (4.1%) additional families for an overall diagnostic yield of 12.6%. The infrastructure and collaborative networks set up by Solve-RD can serve as a blueprint for future further scalable international efforts. The resource is open to the global rare-disease community, allowing phenotype, variant and gene queries, as well as genome-wide discoveries.
Ključne besede:rare diseases, identification, interpretation, genetic diagnosis, genomic variants
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2025
Št. strani:str. 478–489
Številčenje:Vol. 31
PID:20.500.12556/DiRROS-24134 Novo okno
UDK:61:575
ISSN pri članku:1546-170X
DOI:10.1038/s41591-024-03420-w Novo okno
COBISS.SI-ID:239892227 Novo okno
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 19. 6. 2025;
Datum objave v DiRROS:17.11.2025
Število ogledov:116
Število prenosov:67
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Nature medicine
Skrajšan naslov:Nat Med (Online)
Založnik:Nature Publishing Group
ISSN:1546-170X
COBISS.SI-ID:2928916 Novo okno

Gradivo je financirano iz projekta

Financer:EC - European Commission
Številka projekta:779257
Naslov:Solving the unsolved Rare Diseases
Akronim:Solve-RD

Financer:EC - European Commission
Številka projekta:305444
Naslov:RD-CONNECT: An integrated platform connecting registries, biobanks and clinical bioinformatics for rare disease research
Akronim:RD-CONNECT

Financer:EC - European Commission
Številka projekta:825575
Naslov:European Joint Programme on Rare Diseases
Akronim:EJP RD

Financer:EC - European Commission
Številka projekta:676559
Naslov:ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences.
Akronim:ELIXIR-EXCELERATE

Financer:EC - European Commission
Številka projekta:101080249
Naslov:Accelerating drug repurposing for rare neurological, neurometabolic and neuromuscular disorders by exploiting SIMilarities in clinical and molecular PATHology
Akronim:SIMPATHIC

Financer:EC - European Commission
Številka projekta:101080997
Naslov:Reconstruction and Computational Modelling for Inherited Metabolic Diseases
Akronim:Recon4IMD

Licence

Licenca:CC BY-NC-ND 4.0, Creative Commons Priznanje avtorstva-Nekomercialno-Brez predelav 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nc-nd/4.0/deed.sl
Opis:Najbolj omejujoča licenca Creative Commons. Uporabniki lahko prenesejo in delijo delo v nekomercialne namene in ga ne smejo uporabiti za nobene druge namene.

Nazaj